USADA has doubled down on former UFC heavyweight champion Brock Lesnar. The UFC yesterday announced that in addition to the out of competition drug test Lesnar failed stemming from a sample taken on June 28th, he had also failed an in competition test during UFC 200 on July 9th, both of which were administered by USADA. Both drug test failures were for the same substance.
Like Jon Jones, Lesnar is now facing a two-year ban per the UFC / USADA anti-doping policy guidelines, but will also have to face the Nevada State Athletic Commission as they were the regulatory body sanctioning the event in Las Vegas.
After the first positive drug test revelation, Lesnar released a statement via the Associated Press claiming, “We will get to the bottom of this.”
Since the news broke of this second positive drug test neither Lesnar nor his camp have yet to make a statement.
Although the substance in question hasn’t been confirmed by the UFC or USADA, reports coming out of the US claim Lesnar tested positive for clomiphene, which is the same anti-estrogen blocker Jones was popped for.
As a reminder, estrogen blockers help restart natural testosterone production in your body and have been known to be used in combination with performance enhancing drugs in order to reduce side effects usually due to hormone imbalance or hormone therapy.
In the build up to UFC 200, during the pre-fight media conference call, Lesnar responded to accusations of PED use, claiming “I’m a white boy and I’m jacked. Deal with it.” It looks like it’s time for Lesnar to deal with it, two fold.
